These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16232225)

  • 1. Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection.
    Encke J; Findeklee J; Geib J; Pfaff E; Stremmel W
    Clin Exp Immunol; 2005 Nov; 142(2):362-9. PubMed ID: 16232225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination.
    Chen A; Ahlén G; Brenndörfer ED; Brass A; Holmström F; Chen M; Söderholm J; Milich DR; Frelin L; Sällberg M
    J Immunol; 2011 May; 186(9):5107-18. PubMed ID: 21430225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
    Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
    Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens.
    Kuzushita N; Gregory SH; Monti NA; Carlson R; Gehring S; Wands JR
    Gastroenterology; 2006 Feb; 130(2):453-64. PubMed ID: 16472599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial).
    Chernykh E; Leplina O; Oleynik E; Tikhonova M; Tyrinova T; Starostina N; Ostanin A
    Immunol Res; 2018 Feb; 66(1):31-43. PubMed ID: 29164490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.
    Thammanichanond D; Moneer S; Yotnda P; Aitken C; Earnest-Silveira L; Jackson D; Hellard M; McCluskey J; Torresi J; Bharadwaj M
    Clin Immunol; 2008 Sep; 128(3):329-39. PubMed ID: 18524682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
    Tokushige K; Wakita T; Pachuk C; Moradpour D; Weiner DB; Zurawski VR; Wands JR
    Hepatology; 1996 Jul; 24(1):14-20. PubMed ID: 8707253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.
    Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J
    Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a dendritic cell vaccine encoding multiple cytotoxic T lymphocyte epitopes targeting hepatitis C virus.
    Zhou Y; Zhao F; Chen L; Ma L; Wang Y; He Y; Ma Z; Liu H; Guo Y; Zhang Y; Yao Z; Hao C; Jia Z
    Int J Mol Med; 2013 Oct; 32(4):901-9. PubMed ID: 23934073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.
    Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2007 Feb; 25(10):1701-11. PubMed ID: 17240490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?
    Beckebaum S; Cicinnati VR; Gerken G
    Rev Med Virol; 2002; 12(5):297-319. PubMed ID: 12211043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.
    Encke J; Radunz W; Eisenbach C; Geib J; Gehrke S; Pfaff E; Stremmel W
    Eur J Clin Invest; 2007 May; 37(5):396-406. PubMed ID: 17461986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2).
    Duan XZ; He HX; Zhuang H
    J Gastroenterol Hepatol; 2006 Jun; 21(6):970-6. PubMed ID: 16724980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection.
    Rodrigue-Gervais IG; Rigsby H; Jouan L; Sauvé D; Sékaly RP; Willems B; Lamarre D
    J Immunol; 2010 Mar; 184(6):3134-44. PubMed ID: 20173023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.